Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial

By Proactive Investors / December 06, 2023 / www.youtube.com / Article Link

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia ...

Recent News

Gold stocks slump partly on fears of cost increases

March 09, 2026 / www.canadianminingreport.com

Canadian provinces rank high in Fraser Institute Survey

March 09, 2026 / www.canadianminingreport.com

Major producers and most of TSXV gold see strong gains

March 03, 2026 / www.canadianminingreport.com

Big Gold production declining, revenue surging, costs flat

February 23, 2026 / www.canadianminingreport.com

Gold stocks rise with majors outpaced by juniors

February 23, 2026 / www.canadianminingreport.com

See all >